Status:
UNKNOWN
Platelet Rich Fibrin for Tear Trough Rejuvenation
Lead Sponsor:
Rejuva Medical Aesthetics
Conditions:
Tear Trough Hollowing, Under Eye Bags
Eligibility:
All Genders
20-80 years
Phase:
EARLY_PHASE1
Brief Summary
The purpose of this study is to investigate the efficacy and longevity of Platelet Rich Fibrin (PRF) in combination with hyaluronic acid filler for cosmetic volume restoration of the tear troughs. Thi...
Detailed Description
Background: Platelet therapy is quickly becoming an integral aspect of cosmetic treatments. Most notably, Platelet Rich Plasma (PRP) has been used topically or as an injection to stimulate collagen pr...
Eligibility Criteria
Inclusion
- Males/females aged 20-80 who are experiencing moderate volume loss of the tear troughs and/or under eye bags. Eligible subjects will be in generally good health and able to provide a blood sample for treatment.
Exclusion
- Those who fall outside of the age range 20-80 years of age, with chronic health problems including but not limited to thyroid disorders, cancer, blood disease, etc. Those who do not demonstrate volume loss of the tear troughs to the degree that warrants intervention. Conversely, those who are better suited for surgical intervention as opposed to non-surgical injections will not be eligible.
Key Trial Info
Start Date :
November 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2018
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03313934
Start Date
November 1 2017
End Date
November 1 2018
Last Update
October 18 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rejuva Medical Aesthetics
Los Angeles, California, United States, 90025